I just had a meeting with Dr. Pamela Munster, UCSF's clinical trial director, yesterday and she told me about a very exciting new drug that is just starting to recruit:
http://clinicaltrials.gov/ct2/show/N...=mm+302&rank=1
The drug is similar to T-DM1 but is suppose to be better because the chemo molecule that it attaches is more effective. Instead of attaching DM1 to Herceptin, MM-302 attaches an anthracycline - a chemo proven to be more effective in breast cancer. This could really be something!
The only thing about the trial is you can't have had an anthracycline in the past, which many have. Fortunately I qualify for this trial if my next scan shows progression and my brain mets are stable. I can't seem to get access to T-DM1 so I may just give this new drug a try. Who knows? This could be our cure!
Always hoping,
Threaded Mode